Analyst Reports

2025

2024

Date	Report	Author
December 9	Start för fas 1 inom kort (SE)
December 9	Austrian milestone (EN)
November 14	Q3 2024 financial results (EN)
November 1	Reverse Split (EN)
October 21	Early stage biotech company with a phase 3 validated platform
October 15	SIIPL Term Sheet (EN)
August 22	At the gates of Phase I (EN)
August 22	Vid porten till fas 1 (SE)
August 15	2024 Second Quarter Results (EN)
July 11	2024 Rights Issue results (EN)
May 23	Improving cash position (EN)
May 23	Förbättrat kassa inför fas1 (SE)
May 16	024 First Quarter Results (EN)
May 3	2024 Rights Issue (EN)
April 23	AdaptVac Dividend (EN)
April 16	Completion of pre-clinical safety (EN)
February 22	ABNCoV2 milestone payment (EN)
February 15	Breast cancer on stage (EN)
February 15	Bröstcancer i fokus (SE)
February 8	2023 YE Report (Newsflash) (EN)

2023

Date	Report	Author
December 4	Pipeline addition - Nipah
December 4	Spotlight: Cancer vaccine ES2B-C001
November 27	New strategy evolving (EN)
November 27	Ny strategi tar form (SE)
August 17	Evaluating BC strategic options (Newsflash) (EN)
June 27	ABNCoV2 phase II meets primary endpoint (Newsflash) (EN)
June 16	ABNCoV2 strong durability data (Newsflash) (EN)
May 16	2023 Q1 Report (Newsflash) (EN)
April 18	Initial gross proceeds of SEK 54.5m (EN)
March 15	Ever-changing landscape (EN)
March 15	Ett föränderligt landskap (SE)
March 6	2023 Right Issue Announcement (EN)
March 3	Mucosal Vaccine (EN)
February 9	2022 YE Report Newsflash (EN)

2022

Date	Report	Author
December 6	Evaxion CMV vaccine collaboration Newsflash (EN)
November 18	Promising long-term data (EN)
November 18	Lovande långtidsdata (SE)
November 17	9M 2022 Report Newsflash (EN)
October 24	ES2B-C001 positive preclinical data published (EN)
October 18	ABNCoV2 reports positive phase II durability data (EN)
September 22	COVID vaccine phase III trial ongoing (EN)
April 8	Cash position to be further increased (EN)
March 8	A moving target (EN)
March 8	Ett rörligt mål (SE)
March 1	Further progress with COVID-19 vaccine (EN)
January 10	Exciting topline preclinical results for ES2B-C001 (EN)

2021

Date	Report	Author
December 9	Solid data open for final phase (EN)
December 9	Resultat öppnar vägen för slutfas (SE)
December 7	Great ABNCoV2 Phase II top line results (EN)
November 19	Phase 2 data pending (EN)
November 19	Fas 2-resultat inom kort (SE)
November 17	COVID-19 vaccine Phase II readout on the horizon (EN)
August 23	Funding still pending (EN)
August 23	I väntan på finansiering (SE)
August 20	Initiation of Phase II trial just around the corner (EN)
August 9	Great COUGH-1 headline results (EN)
June 24	Rights to COVID-19 Challenge (Initiation) (EN)
April 22	First human data reassuring (EN)
April 22	Första data på människa (SE)
January 27	Getting Close To Patients (EN)
January 27	Test På Människa Inom Kort (SE)